Carb-X

CARB-X Funding Rounds Q&A #1
2023-04-20 18:00 - 19:00 (America/New_York)
Register here for the 1st of 2 Q&A sessions on the upcoming CARB-X funding rounds.

CARB-X Funding Rounds Q&A #2
2023-04-21 08:00 - 09:00 (America/New_York)
Register here for the 2nd of 2 Q&A sessions on the upcoming CARB-X funding rounds.

Financial Times Live Panel: National health security – Addressing rising threats
2023-05-17 13:35 - 14:20 (America/New_York) | VIRTUAL EVENT
The coronavirus pandemic was a wake-up call for those inclined to ignore emerging health threats. Looking to the future, whether it be another virus, mental health, or noncommunicable diseases such as diabetes and dementia, the US must consider its options to avoid or at least minimize the impact of health threats with the potential to cause even more pain if ignored.

How can stakeholders work together to prepare for epidemics and pandemics of the future?
What can be done to support health systems in handling the rise of chronic conditions such as obesity and dementia?
What advances are we seeing in treatment of increasingly prevalent conditions such as Alzheimer’s, diabetes and cancer?
As recognition and understanding of mental health evolves, how could treatments change?

Speakers:
Kevin Outterson, Austin B. Fletcher Professor, Boston University, Executive Director and Principal Investigator, CARB-X
Rasmus Besch Hansen, CEO and Founder, Airfinity
Olivier Bogillot, Head of US General Medicines, Sanofi
Julie Gerberding, CEO, Foundation for the National Institutes of Health
Andrew Jack, Global Education Editor, Financial Times

BSAC Spring Conference
2023-05-18 08:00 - 2023-05-19 17:00 (America/New_York)
ADDRESSING THE AMR BURDEN IN EVERYDAY PRACTICE

76th World Health Assembly
2023-05-21 08:00 - 2023-05-30 17:00 (America/New_York)
The World Health Assembly is the decision-making body of WHO. It is attended by delegations from all WHO Member States and focuses on a specific health agenda prepared by the Executive Board. The main functions of the World Health Assembly are to determine the policies of the Organization, appoint the Director-General, supervise financial policies, and review and approve the proposed programme budget. The Health Assembly is held annually in Geneva, Switzerland.

BIO Boston 2023
2023-06-05 08:00 - 2023-06-08 17:00 (America/New_York) | Boston Convention Center, 415 Summer St, Boston, MA, 02210, United States
Stand up for innovation. Stand up for truth. And stand up for science. It’s time to inspire, honor, and recognize the true value of the breakthrough work biotech performs for society. Today. And every day. Well into the future.

Engaging the Pharmaceutical Industry in Joint Efforts to Tackle ANTIMICROBIAL RESISTANCE
2023-06-10 15:00 - 17:30 (Asia/Kolkata)
A webinar focused on AMR issues pertinent to India such as:

What is the current status of antibiotic development in the pipeline, both in India and globally?
What are some potential strategies or incentives to stimulate anti-infective development in India?
What role can the Indian pharmaceutical industry play in global efforts to develop new anti-infectives?
How can we ensure the availability and affordability of new antibiotics in India while maintaining their responsible use?

Register here to join the conversation.

Boston Bacterial Meeting 2023
2023-06-12 08:00 - 2023-06-13 17:00 (America/New_York) | Harvard Science Center
The meeting will be held at the Harvard Science Center, 1 Oxford St, Cambridge, MA 02138. Please visit our Directions page for information on public transit and parking.

The keynote address for BBM 2023 will be delivered by Dr. Kumaran Ramamurthi from the NIH. Dr. Ramamurthi is a renowned bacterial cell biologist who has made important contributions to our understanding of how morphogenetic proteins localize to specific sites and drive essential processes such as spore formation and cell division. Please visit our Keynote Speaker page for more information about his career and accomplishments.

About BBM

BBM was founded in 1995 by two postdocs from Richard Losick’s lab at Harvard, Kit Pogliano and Karen McGovern, with the goal of bringing bacteriologists from the greater Boston area together to present their work and share ideas. BBM, now in its 29th year, has proven to be a vibrant meeting, attended not only by bacteriologists from the Boston area but from all over the country. Keeping with its roots, the conference is being planned and organized by a committee of students, postdocs, and other early career researchers. This year, the organizational committee is co-chaired by Alam García-Heredia, a postdoc in Alan Grossman’s lab at MIT, and Shailab Shrestha, a graduate student in Aimee Shen’s lab at Tufts.

ASM Microbe 2023
2023-06-15 08:00 - 2023-06-19 17:00 (America/New_York) | George R. Brown Convention Center, Houston, TX
Join thousands of scientists, researchers and healthcare professionals in your field, who are all traveling to Houston, TX from June 15-19 for the largest microbial sciences gathering in the world! Andy Weir, John Nkengasong and Edward Holmes are just some of the world-renowned speakers lined up in ASM Microbe’s cutting-edge scientific program.
Plus, do you have late-breaking research? There is still time to join our robust scientific program! Emerging Abstract Submissions Opens April 4. Don’t miss the opportunity to present your research and learn about the latest science from experts and leaders in your field.
ASM Microbe 2023 will cover:

Disaster Microbiology.
Emerging Infections – What is the Next pandemic? (Focus on Nipah and Marburg).
Natural Product Discovery and Synthesis.
The Next Generation Antifungal Agents: Clinical Application and Resistance.
Combating the Climate Crisis with Critters: Microbial Carbon Capture.
Powering the Future: Applied Microbiology in the Energy Industry.
Equity and Access in Laboratory Diagnostics.
Microbiome Management in a Changing World.
New Perspectives on Phage Therapy to Treat Multidrug Resistant Infections.
Beyond Academia: Fulfilling Microbiology Careers Outside the Tenure Track.
The Perks of Being Squishy: Archaea as a Skillful Mechanoresponsive Machine.
What is the Microbiota Really Doing in Neuroinflammatory Diseases?
And so much more!

ACS Fall Meeting - The Future of Antibiotic Drug Discovery
2023-08-13 08:00 - 2023-08-17 17:00 (America/New_York) | San Francisco, CA
Where thousands of chemistry professionals meet to share ideas and advance scientific and technical knowledge.

World AMR Congress 2023
2023-09-07 08:00 - 2023-09-08 17:00 (America/New_York) | Pennsylvania Convention Center, Philadelphia, PA
THE WORLD’S LARGEST AMR CONFERENCE FOR ALL STAKEHOLDERS COMBATING ANTI-MICROBIAL RESISTANCE

2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
2023-09-19 08:00 - 2023-09-22 17:00 (America/New_York) | Boston, MA
The 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance is scheduled to take place Sept. 19-22, 2023 in Boston, Mass.
Co-sponsored by ASM and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will highlight the challenges, opportunities and current requirements for antimicrobial drug development to address antimicrobial resistance.

Canada Webinar
2023-10-05 13:00 - 14:00 (America/New_York)
You are invited to an exclusive webinar for Canada by CARB-X on Thursday, Oct. 5th at 1pm Eastern. This webinar will highlight the importance of antibacterial R&D, provide an overview of CARB-X, and describe how Canadian organizations and individuals may work with CARB-X in the future, including receiving financial, scientific, regulatory and business support. The presenters will be Richard Alm, the Chief Scientist of CARB-X, and Rich Lawson, a member of the CARB-X executive team. There will be approximately 30 minutes of presentation and then time for questions and answers.
Please click here to register.

ID Week 2023
2023-10-11 08:00 - 2023-10-15 17:00 (America/New_York) | Boston Convention Center, 415 Summer St, Boston, MA, 02210, United States
IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS), and the Society of Infectious Diseases Pharmacists (SIDP).

World Health Summit 2023
2023-10-15 08:00 - 2023-10-17 17:00 (America/New_York) | Berlin, Germany
The World Health Summit is the unique international strategic forum for global health. Held annually in Berlin, it brings together stakeholders from politics, science, the private sector, and civil society from around the world to set the agenda for a healthier future by inspiring innovative solutions for better health and well-being for all.
The World Health Summit was founded in 2009 on the occasion of the 300th anniversary of Charité – Universitätsmedizin Berlin. It is traditionally held under the patronage of the German Chancellor, the French President, the President of the European Commission, and the Director-General of the World Health Organization (WHO). President of the World Health Summit is Axel R. Pries, Dean of Charité.
In addition to the World Health Summit in Berlin, there are annual Regional Meetings and regular Expert Meetings around the world. These meetings are organized by the M8 Alliance, the academic backbone of the World Health Summit.

BSAC Winter Conference 2023
2023-11-30 08:00 - 2023-12-01 17:00 (America/New_York)
Infection 2023: BSAC Winter Conference – Addressing AMR across the tightrope of politics, policy and practice

Lorne Infection & Immunity 2024
2024-02-14 08:00 - 2024-02-16 17:00 (America/New_York)
The Lorne Infection and Immunity Conference brings together scientists, students, health care and industry from multiple disciplines with a shared interest in infection and immunity research.
Registrations are open and abstracts are now being accepted.
ECR awards, subsidised student registrations, an amazing speaker list, networking and social events, and the return to our face-to-face meeting format combined with the advantages of online participation, mean participation is accessible to everyone and there is every reason to join in.
See below for links to register and for more information.
2024 THEMES
Host-pathogen interactions
Molecular basis of infectious diseases
Innate immunity
Adaptive immunity
Advances in immunotherapy vaccines and clinical translation
New solutions for antimicrobial resistance
Emerging infectious diseases and global health

8th AMR Conference
2024-03-06 08:00 - 2024-03-07 17:00 (America/New_York)
The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and specific challenges faced by the innovation ecosystem in bringing new antimicrobial treatments and diagnostics to the market.
The conference is the one-stop shop to catch up with the latest trends in the development of AMR products, by covering scientific, regulatory, financial and policy topics. Besides high-level talks, the conference is a great place to network and exchange views on innovative technologies, development paths and alternative business models with your peers. The conference also offers a partnering platform to facilitate interactions.
The 7th edition covered the whole innovation value chain, including scientific breakthrough, preclinical and clinical development, but also financial topics such as public funding for R&D, market incentive and investors’ perspective. Specific sessions were also dedicated to antimicrobials in the environment, diagnostics, antifungals, biologics and anti-tuberculosis drug combinations. There was a special focus on India and how the country is getting prepared to provide global solutions against AMR. Among other highlights were a start-up competition, hosted by the pharma-backed incubator INCATE, and a poster prize.

The AMR Conference is jointly organized by BEAM Alliance and bamconn GmbH.
The BEAM Alliance is one of the major supporting partners of the AMR Conference. Launched in June 2015, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance gathers more than 70 small and medium-sized European biotech and diagnostics companies committed to developing innovative products for fending off antibiotic-resistant pathogens. BEAM Alliance carries the voice of SMEs to support policies and incentives in antimicrobial research and development in Europe.
bamconn GmbH was established in November 2022 as a spin-off of BIOCOM AG and continues its entire event management as an independent company. It is built on more than 15 years of experience in the planning, organization and implementation of scientific events and exhibitions. The portfolio covers the entire spectrum from small workshops with 20 participants to multi-day international conferences for up to 2,000 people as well as exhibitions on the topic of bioeconomy throughout Europe. Customers for whom the bamconn team worked so far are companies, research institutions, associations and federal ministries as well as subordinate authorities and EU-funded projects.

Antimicrobial Resistance - Genomes, Big Data and Emerging Technologies
2024-03-13 08:00 - 2024-03-15 17:00 (America/New_York)
Antimicrobial resistance (AMR) is a major challenge in our globalised world, and tackling it will take the combined resources and effort of researchers working across different disciplines. Technical advances in recent years continue to expand our ability to collect vast amounts of genomic information on pathogens, and a wealth of data is being collected in epidemiological and surveillance studies, including on the socio-economic burden of AMR.
Our 4th conference in this series will bring together basic researchers, clinicians, computer scientists, and policymakers interested in pathogen genomics, epidemiology, surveillance, and machine learning to explore the recent advances and current challenges of the field.
This year’s programme will once again focus on genomic evidence and how to implement it in clinical practice and policy for AMR control. The meeting will highlight the advances in machine learning, AI and computational tools to predict AMR. We will also discuss how to build an international genomics infrastructure to tackle AMR and emerging lessons from other global public health issues.
This conference will be a hybrid meeting – with onsite or virtual attendance. In addition to invited talks, the programme will include short oral presentations selected from abstracts, posters, poster pitches and networking breaks for further discussion.

COMBINE Webinar | Development of Target Product Profiles for Antibiotics
2024-03-15 14:30 - 16:00 (Europe/Brussels)
Calling all #healthcare innovators! 📢 Don’t miss out on the IMI COMBINE project webinar discussing Target Product Profiles for #antibiotic development. Join industry leaders from CARB-X, Evotec, and GSK on March 15, 14:30 – 16:00 CET.
Dr. Erin Duffy, Chief of R&D of CARB-X, will be a panelist.
To register: https://limesurvey.biocom.de/index.php/191531?lang=en&newtest=Y
For more details on the webinar: https://amr-accelerator.eu/event/combine-webinar-on-developing-target-product-profiles-for-antibiotics/

Gordon Research Conference | Innovative Approaches in Antibacterial Research and Development to Fight the Antibiotic Resistance Crisis
2024-03-17 08:00 - 2024-03-22 17:00 (America/New_York)
The New Antibacterial Discovery and Development GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.

The antibiotic resistance crisis is among us, and with it, the urgent need to tackle this global health threat has never been greater. Yet each step in the discovery and development process, from target validation and inhibitor optimization to clinical trial design and product commercialization, poses formidable challenges. The New Antibacterial Discovery and Development GCR will turn these challenges into opportunities to promote interdisciplinary innovation while addressing the global need for more effective antibiotic therapies.
The conference will offer a forum where participants of all backgrounds and career stages explore solutions to current bottlenecks in antibacterial drug development, creating bridges between Academia, Industry, and Governments. Importantly, the meeting will provide early career researchers and trainees ample networking opportunities with highly experienced leaders in a positive and inclusive environment. We hope to see you in Ventura!

Novel Diagnostics for Infectious Diseases
2024-03-25 08:00 - 2024-03-26 17:00 (America/New_York)
This two-day meeting will delve into common challenges shared by diagnostics developers. Through presentations and panel discussions, attendees will explore topics such as Technologies and Challenges, Regulatory and Adoption Challenges, and Regulation and Policy Perspectives.
This workshop is co-organised and funded by Imperial College London’s Institute of Infection, B2B2B Network, London In Vitro Diagnostics Co-operative, NIHR Biomedical Research Centre, and DIAMONDS consortium. Funding is also provided by the UKRI IAA Healthy Society award and the Rosetrees Trust.

Betsy Wonderly Trainor, Alliance Director at CARB-X, will be a speaker during the “Funding innovative diagnostics: Lessons learnt and roadmap to future impact” session.

World Vaccine Congress
2024-04-01 08:00 - 2024-04-04 17:00 (America/New_York)
R&D + STRATEGIC PARTNERING FOR THE GLOBAL VACCINE INDUSTRY
The World Vaccine Congress is the largest, most established meeting dedicated to vaccines.
From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain where science, government and manufacturers all come together to create groundbreaking progress.

ECCMID 2024
2024-04-27 08:00 - 2024-04-30 17:00 (America/New_York)
Embrace the best of both worlds at ECCMID 2024 taking place 27-30 April 2024 in Barcelona, Spain! Engage in a cutting-edge medical congress, while experiencing the city’s irresistible charm. Barcelona offers the perfect fusion of knowledge and adventure.
ECCMID 2024 will follow the successful format introduced in 2022, offering a comprehensive hybrid congress. While we encourage the majority of our faculty, abstract presenters, and attendees, to participate on-site and benefit from the scientific, educational and networking experiences, provided by ECCMID, our seamless hybrid solution allows remote attendance for those unable to travel for any reason. Whether you come and join us in Barcelona, Spain or sign in online from your living room or office, you will be able to fully enjoy what ECCMID 2024 has to offer.

5th H3D Symposium
2024-05-21 08:00 - 2024-05-24 17:00 (America/New_York)
We are excited to announce that the 5th H3D Foundation Symposium will be taking place from 21 to 24 May 2024 at the Radisson Blu Mosi-Oa-Tunya Livingstone Resort in Zambia.
The symposium is a pinnacle event for H3D, following the success of the previous four symposia held in Cape Town and Livingstone.
The 5th H3D Symposium will be held at the prestigious Radisson Blu Mosi-Oa-Tunya Livingstone Resort in Zambia, providing a captivating backdrop near the magnificent Victoria Falls on the banks of the Zambezi River.
This symposium will focus on the theme “Emerging Treatments for Drug-Resistant Infections of Bacterial and Mycobacterial Origin,” addressing the pressing challenge of antimicrobial resistance (AMR).
What to expect:

Face-to-face exposure to more than 150 local, regional, and international delegates from tertiary institutions and the pharmaceutical industry, scientists, and researchers with a specific interest in TB, AMR & NTDS.
An innovative programme comprising instructional course lectures (ICLs), the latest research, keynote lectures, oral and rapid-fire sessions and ePosters.
Interaction between high-profile, distinguished international scientists and diverse participants, including postgraduate students and postdoctoral fellows.
A platform to present your latest research, product development, science, and capabilities to a global audience.
Provides your company and your products visibility.

Register to attend
Secure your spot and participate in this exceptional event by registering online today!

Boston Bacterial Meeting 2024
2024-06-03 08:00 - 2024-06-04 17:00 (America/New_York) | Boston University
The meeting will be held at Boston University at the George Sherman Union, 775 Commonwealth Ave, Boston.
The keynote address for BBM 2024 will be delivered by Dr. Joe Bondy-Denomy, UCSF. Joe Bondy-Denomy is an Associate Professor at UCSF. Dr. Bondy-Denomy earned his PhD from University of Toronto working in the lab of Alan Davidson. During this time, he studied the interactions between bacteriophages and Pseudomonas aeruginosa. He became especially interested in the role of bacterial CRISPR/Cas systems in defending against phages and the strategies phages use to overcome CRISPR/Cas systems. Specifically, he found that phages encode anti-CRISPR proteins that block the activity of CRISPR/Cas systems. He started his lab at UCSF in 2015 as a Sandler Faculty Fellow with a focus on understanding the interplay between bacterial CRISPR/Cas systems and phage anti-CRISPRs. He was promoted to Assistant Professor in 2017 and Associate Professor in 2020. His lab’s research has revealed fascinating insight into the interactions between bacteria and phages including discoveries of countless anti-CRISPR proteins, elucidation of the mechanisms through which CRISPR/Cas systems and anti-CRISPR proteins are regulated, and more recently investigation of novel mechanisms of phage defense and phage evasion. His lab has used understanding of CRISPR/Cas systems to improve methods for editing the genomes of bacteria and phages hoping that this will ultimately to support the development of phage therapies.
About BBM
BBM was founded in 1995 by two postdocs from Richard Losick’s lab at Harvard, Kit Pogliano and Karen McGovern, with the goal of bringing bacteriologists from the greater Boston area together to present their work and share ideas. BBM, now in its 30th year, has proven to be a vibrant meeting, attended not only by bacteriologists from the Boston area but from all over the country. Keeping with its roots, the conference is being planned and organized by a committee of students, postdocs, and other early career researchers. This year, the organizational committee is co-chaired by Molly Sargen, a graduate student in Sophie Helaine’s lab at Harvard Medical School, and Laurent Dubois, a graduate student in Tom Bernhardt’s lab at Harvard Medical School.

BIO San Diego
2024-06-03 08:00 - 2024-06-06 17:00 (America/New_York)
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the globe.
Whether you work at a public pharmaceutical company, biotech startup, academia, non-profits, and government or are a researcher, business development professional or investor, BIO is where you’ll make valuable connections and build relationships. Our proprietary BIO One-on-One Partnering™ match-making platform—included in the Premier Access registration package—allows you to find potential partners, schedule and accept meetings.

ASM Microbe
2024-06-13 08:00 - 2024-06-17 17:00 (America/New_York)
Scientific Breakthroughs Begin at ASM Microbe

Join us in Atlanta, June 13-17, 2024!
As the world’s largest microbial sciences conference, ASM Microbe is the best place to showcase your research, engage with global leaders and forge new connections with scientists, researchers and educators, just like you. Dive deep into groundbreaking discoveries across 8 scientific tracks and tailor your experience with our unique meeting-within-a-meeting format. Whether you immerse yourself in the broader conference or focus on your specialty, an unparalleled experience awaits!

Global Health Security Conference 2024
2024-06-18 08:00 - 2024-06-21 17:00 (America/New_York)
Welcome to our third Global Health Security conference, which returns to Sydney, Australia, in June 2024! Even as the COVID-19 pandemic remains ongoing, the health challenges people confront from a changing climate, zoonotic pathogens, microbial resistance, conflict, and the social, political and economic determinants of health that exacerbate poor health, exposure to disease, and an inability to access affordable healthcare services, can seem insurmountable at times. Yet by working collaboratively to bring multiple stakeholders from across disciplines and professions where we can share learnings, research, policy innovations and solutions, we can build a safer and healthier world for all. Join us in Sydney to be part of this important dialogue!

World AMR Congress 2024
2024-09-05 08:00 - 2024-09-06 17:00 (America/New_York) | Pennsylvania Convention Center, Philadelphia, PA
Since 2015, the World Anti-Microbial Resistance Congress has been the go-to conference globally for all stakeholders in the AMR space to meet, brainstorm ideas and formulate initiatives that can effectively tackle antimicrobial resistance.
Join us for the World AMR Congress and get full access to the Disease Prevention & Control Summit co-located at the Pennsylvania Convention Center on September 5-6
